Description of event:
International Conference on Central Nervous System - Drug Effects & Novel Drug Development
the International Conference on Central Nervous System -
Drug Effects & Novel
Drug Development during September 5-7, 2012 at DoubleTree by Hilton Philadelphia, USA.
Central Nervous System-2012 is a remarkable event which brings together all the leading universities, Central Nervous System researchers as well as institutions, making the conference a perfect platform to share experiences, foster collaborations across industry and academia and also evaluate emerging technologies across the globe.
International Conference on Central Nervous System -
Drugs Effects, Novel
Drug Development will schedule and coordinate all meetings with our Editorial Board Members and other experts in the Research of Central Nervous System across the world. The scientific program paves a way to gather visionaries through the research talks and presentations and put forward many thought provoking strategies.
Conference highlights the following topics:
• Disorders related to CNS
• Behavioral Neurology
•
Clinical Neurophysiology
•
Oncology of Central Nervous System
• Neurodegenerative Diseases
• Remedies for CNS & Neurological Disorders
• CNS
Biomarkers
•
Clinical Trials on CNS
•
Drug Metabolism in
Drug Design and
Drug Interactions
Central Nervous System-2012 is comprised of 13 tracks and 68 sessions designed to offer comprehensive sessions that address
current issues in Central Nervous System.
Drug Discovery and Development in Neurosciences
Track 1-1: Neuropharmacology, ADME/T in
drug discovery
Track 1-2: Anti-neurodegenerative
drug discovery
Track 1-3:
Ion channels,
transporters and
neurotransmitter receptors
Track 1-4: Neural
stem cells and
gene or
cell therapy
Track 1-5:
Neurotransmitters, neuromodulators, and neuroreceptors
Track 1-6: Centrally acting analgesics
Track 2:
Drug Metabolism in
Drug Design
Track 2-1:
Blood brain barrier (BBB)
Track 2-2:
Metabolism mediated
drug-
drug interactions
Track 2-3:
Enzyme kinetics
Track 2-4: Role of
drug metabolism in
drug development
Track 2-5:
Nanoparticles as
drug carriers
Track 3:
Clinical Trials on CNS
Track 3-1:
Clinical development in
MS, PD and AD
Track 3-2:
Biomarkers implication in
clinical trials
Track 3-3: Schizophrenia and depression
Track 3-4:
Current challenges in translational CNS research
Track 3-5: Facilitating and establishing industry and academic partnering
Track 4: Neurological
Drug Targets
Track 4-1: Properties of
drug molecules
Track 4-2:
Therapeutic target discovery
Track 4-3: Target
validation
Track 4-4: Lead optimization
Track 4-5:
Drug delivery systems
Track 5: Disorders Related to CNS
Track 5-1: Acoustic neuroma
Track 5-2: Encephalitis
Track 5-3: TJuvenile huntington
disease
Track 5-4: Spinal meningitis
Track 5-5: Motor
neuron disease
Track 5-6: Hydrocephalus
Track 5-7: Therapeutics of sleep disorders
Contact us:
Conference Secretariat: Central Nervous System-2012, OMICS Group Conferences
5716 Corsa Ave., Suite 110, Westlake, Los Angeles, CA 91362-7354, USA